Invicta Diagnostic MD, chairman, board of directors and AGM
NSE: INVICTAHealthcare Services
Share price at the NSE close on 23 Oct 2026. Previous close ₹64.70.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹76 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 18 May 2026
- 15.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 18 May 2026
- 1.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 18 May 2026
- 9.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 18 May 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 18 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 8,000100.0% delivered
Invicta Diagnostic board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Kanak Rathod & CoPeer-review certificate valid to Feb 2029
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Invicta Diagnostic AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Invicta Diagnostic share news and announcements
Annual general meeting, 19 Sep 2026
414 shareholders on the register on 12 Sep 2026; present: 14 promoters and 2 others; votes counted by Shrenik Nagaonkar / Shrenik Nagaonkar and Associates.The company's voting result (opens in a new tab)
To consider and adopt (a) the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026 and the report of Auditors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 67.88% · promoters 99.71% · institutions 0.00% · other public 5.01%
- To appoint a director in place of Mr. Ketan Jayantilal Jain (DIN: 07819226), who retires by rotation and, being eligible, seeks re-appointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 67.88% · promoters 99.71% · institutions 0.00% · other public 5.01%
- Appointment of M/s Shrenik Nagaonkar & Associates, Company Secretaries as Secretarial Auditor of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 67.88% · promoters 99.71% · institutions 0.00% · other public 5.01%
- Appointment of Mr. Sanket Vinod Jain (DIN: 08299039) as Managing Director of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 67.88% · promoters 99.71% · institutions 0.00% · other public 5.01%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 17 Apr 2026, 16 resolutions
407 shareholders on the register on 10 Apr 2026; present: 16 promoters and 9 others; votes counted by Shrenik Uday Nagaonkar / Shrenik Nagaonkar and Associates.The company's voting result (opens in a new tab)
- Regularization of Additional Director, Mr. Rohit Prakash Srivastava (DIN: 01432112) as Whole-Time Director (Finance) of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.58% · promoters 100.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with PCD Diagnostics LLP.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with Pratham MRI and CT Scan Centre.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with Primacare Healthcare LLP.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with Invicta Medical LLP.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with Primacare Diagnostic LLP.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with Mscribeit Infotech LLP.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with Porteus Medical LLP.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with Invicta Diagnostic Lifecare LLP.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with Invicta Diagnostic Healthplus LLP.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval of Material Related Party Transaction with Shegaon Diagnostic LLP.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval for payment of remuneration to Ms. Komal Sanket Jain a related party for holding the office or place of profit.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval for payment of remuneration to Ms. Garima Naredi a related party for holding the office or place of profit.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval for payment of remuneration to Ms. Aditi Jayesh Jain a related party for holding the office or place of profit.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval for payment of remuneration to Ms. Payal Kunal Jain a related party for holding the office or place of profit.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 5.88% · promoters 0.00% · institutions 0.00% · other public 23.60%
- Approval for Change, Deviation and Variation in the Objects and terms of Utilisation of the Initial Public Offering (“IPO”) Proceeds and extension of time limit for utilisation of the IPO Proceeds.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.58% · promoters 100.00% · institutions 0.00% · other public 23.60%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2026.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesDec 2025 | 28.12 | Issue related Expenses | 2.94 | 2.79 | No |
| Public IssuesDec 2025 | 28.12 | Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra | 21.11 | 2.28 | No |
| Public IssuesDec 2025 | 28.12 | General Corporate purposes | 4.07 | 2.38 | No |